Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03473652
Other study ID # APPAHOCA
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 29, 2018
Est. completion date December 11, 2018

Study information

Verified date March 2018
Source Centre Francois Baclesse
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigator propose to evaluate the interest of the provision of a suitable treadmill offering fall protection and verticalization assistance.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date December 11, 2018
Est. primary completion date October 11, 2018
Accepts healthy volunteers No
Gender All
Age group 70 Years and older
Eligibility Inclusion Criteria:

- Patient with cancer

- Patient over 70 years old hospitalized 48 hours or more

- Patient identified as eligible for medical prescription of Adapted physical activity

- Mastery of the French language ;

- Patient affiliated to a social security scheme

- Patient giving written consent

Exclusion Criteria:

- Patient totally unable to communicate

- Patient in terminal palliative care

- Patient with a size <1m35 or> 2m and / or a weight> 130kg

- Patient unable to perform Adapted physical activity sessions

- Patient unable to wear a restraint harness.

- Patient deprived of liberty or under guardianship

- Patient unable to comply with protocol requirements for geographical, social or psychopathological reasons

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Adapted walking platform
The walking sessions will be carried out on a suitable walking platform, including a connected play tablet.

Locations

Country Name City State
France Centre François Baclesse Caen
France CHU Caen

Sponsors (1)

Lead Sponsor Collaborator
Centre Francois Baclesse

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patient adherence to use a walking Platform Adapted physical activity on a walking platform will be considered feasible if > or = to 70% of patients perform > or = to 2 sessions of 6 minutes or more during hospitalization for cancer lasting > or = to 48h 2 days
See also
  Status Clinical Trial Phase
Completed NCT01439152 - Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors. Phase 1
Recruiting NCT05615246 - Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
Active, not recruiting NCT06015009 - Symptom Management App for Children at the Early Stage of Cancer Survivorship and Their Caregivers N/A
Active, not recruiting NCT03298100 - Risk Scoring Model for Endometrial Cancer
Recruiting NCT05055609 - Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors Phase 1
Not yet recruiting NCT04324320 - Psychological Distress in Outpatient Oncological Rehabilitation
Completed NCT00588289 - Long Term Follow-Up of Patients on Children's Cancer Group Protocols- (CCG-LTF1) FOLLOW-UP DATA N/A
Recruiting NCT06222801 - The 1st Tumor CytokinoTherapy Database (TCTD-1)
Recruiting NCT03831633 - Comparative Effectiveness of AKYNZEO® and Standard of Care (Including EMEND®) for the Prevention of Nausea and Vomiting (CINV) in Cancer Patients Phase 4
Completed NCT04914702 - Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer.
Recruiting NCT05198570 - Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients
Recruiting NCT05712174 - A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer Phase 2
Recruiting NCT03832062 - Value of Analysing Under-utilised Leftover Tissue (VauLT)
Completed NCT03988777 - Magnetic Seed Localisation for Nonpalpable Breast Lesions
Recruiting NCT06031233 - Evaluating the Safety of Shortened Infusion Times for dIfferent Oncological Immunotherapie Phase 4
Enrolling by invitation NCT04019119 - Digital Intervention for the Modification of Lifestyles (iGame) N/A
Not yet recruiting NCT05926362 - Capillary-Venous Paired Data Collection
Recruiting NCT05686213 - ExeNTrO: Exercise During Neoadjuvant Chemoradiation Treatment to Improve Rectal and Esophageal Cancer Outcome - Pilot Trial Phase 2
Recruiting NCT05510856 - Comparative Clinical Study Evaluating the Possible Efficacy of Duloxetine, Gabapentin and Lacosamide on Oxaliplatin-Induced Peripheral Neuropathy in Cancer Patients Phase 4
Completed NCT04180306 - PEWS Implementation in an LMIC Setting N/A